MCB6A organoids generate urothelial tumors with features similar to the basal-squamous subtype of urothelial carcinoma, the most common bladder cancer. MCB6A harbors 1,524 mutations, including mutations in Kdm6a and Trp53.

Publication: CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade